1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. Y-MABS THERAPEUTICS INC
Y-Mabs Therapeutics Inc XNAS: YMAB

Y-Mabs Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

about

Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved prod...

Read More
8.51 -0.01 (-0.12%)
2.8M

XNAS 08 Aug, 2025 5:30 PM (EDT)

Board Meeting
The next board meeting for Y-Mabs Therapeutics Inc is on 12 Aug 2025 for the purpose of Y-mAbs Therapeutics Inc Second Quarter Earnings Results for 2025 See details
Low Financial Strength
22.2 / 100
Expensive Valuation
14.3 / 100
Technically Moderately Bullish
63.2 / 100
Momentum Trap These stocks are with a bad quality and poor financial score ranging from medium to expensive valuation. Rising technical aspects may attract investors, but, weak financials cannot be overlooked. View Similar Embed DVM

Y-Mabs Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..